176 related articles for article (PubMed ID: 23092586)
1. [Ribonucleotide reductase and non-small cell lung cancer].
Hsu NY; Lee H; Cheng YW; Yen Y
Zhongguo Fei Ai Za Zhi; 2012 Nov; 15(11):619-23. PubMed ID: 23092586
[No Abstract] [Full Text] [Related]
2. P53R2, p53 inducible ribonucleotide reductase gene, correlated with tumor progression of non-small cell lung cancer.
Uramoto H; Sugio K; Oyama T; Hanagiri T; Yasumoto K
Anticancer Res; 2006; 26(2A):983-8. PubMed ID: 16619496
[TBL] [Abstract][Full Text] [Related]
3. Expression status of ribonucleotide reductase small subunits hRRM2/p53R2 as prognostic biomarkers in stage I and II non-small cell lung cancer.
Hsu NY; Wu JY; Liu X; Yen Y; Chen CY; Chou MC; Lin CH; Lee H; Cheng YW
Anticancer Res; 2011 Oct; 31(10):3475-81. PubMed ID: 21965764
[TBL] [Abstract][Full Text] [Related]
4.
Hu N; Wang YH; Li DQ; Yang XH; Tan YL
Chin Med J (Engl); 2017 Sep; 130(17):2117-2118. PubMed ID: 28836557
[No Abstract] [Full Text] [Related]
5. Mouse ribonucleotide reductase: from genes to proteins.
Filatov D; Ingemarson R; Johansson E; Rova U; Thelander L
Biochem Soc Trans; 1995 Nov; 23(4):903-5. PubMed ID: 8654863
[No Abstract] [Full Text] [Related]
6. [A Case Report of Pulmonary Sarcomatoid Carcinoma with ALK Rearrangement].
Miao Y; Ling L; Zhang X; Huang J
Zhongguo Fei Ai Za Zhi; 2017 May; 20(5):366-370. PubMed ID: 28532546
[No Abstract] [Full Text] [Related]
7. Stable glycyl radical from pyruvate formate-lyase and ribonucleotide reductase (III).
Knappe J; Wagner AF
Adv Protein Chem; 2001; 58():277-315. PubMed ID: 11665490
[No Abstract] [Full Text] [Related]
8. A Case of Concurrent De Novo C797S and L858R EGFR Mutation Detected in Stage IA Non-Small Cell Lung Cancer Patient.
Lee JS; Hur JY; Kim HJ; Lee KY; Kim WS
J Thorac Oncol; 2017 Nov; 12(11):e179-e181. PubMed ID: 29074208
[No Abstract] [Full Text] [Related]
9. Cloning and functional analysis of the ribonucleotide reductase gene small subunit from hydroxyurea-resistant Leishmania mexicana amazonensis.
Lye LF; Hsieh YH; Su KE; Lee ST
Mol Biochem Parasitol; 1997 Dec; 90(1):353-8. PubMed ID: 9497060
[No Abstract] [Full Text] [Related]
10. Lung cancer and the human gene for ribonucleotide reductase subunit M1 (RRM1).
Pitterle DM; Kim YC; Jolicoeur EM; Cao Y; O'Briant KC; Bepler G
Mamm Genome; 1999 Sep; 10(9):916-22. PubMed ID: 10441745
[TBL] [Abstract][Full Text] [Related]
11. Afatinib in Osimertinib-Resistant EGFR ex19del/T790M/P794L Mutated NSCLC.
van Kempen LC; Wang H; Aguirre ML; Spatz A; Kasymjanova G; Vilacha JF; Groves MR; Agulnik J; Small D
J Thorac Oncol; 2018 Sep; 13(9):e161-e163. PubMed ID: 29704676
[No Abstract] [Full Text] [Related]
12. Is caspase-8 a neuroendocrine lung tumor suppressor?
Mazumder S; Almasan A
Cancer Biol Ther; 2002; 1(1):70-1. PubMed ID: 12197486
[No Abstract] [Full Text] [Related]
13. Is the mammalian ribonucleotide reductase really like Escherichia coli's ribonucleotide reductase?
Whitfield JF; Youdale T
Pharmacol Ther; 1985; 29(3):407-19. PubMed ID: 3915361
[No Abstract] [Full Text] [Related]
14. Broad overexpression of ribonucleotide reductase genes in mice specifically induces lung neoplasms.
Xu X; Page JL; Surtees JA; Liu H; Lagedrost S; Lu Y; Bronson R; Alani E; Nikitin AY; Weiss RS
Cancer Res; 2008 Apr; 68(8):2652-60. PubMed ID: 18413732
[TBL] [Abstract][Full Text] [Related]
15. Successful Treatment of a Miliary Metastatic NSCLC Patient With Activating EGFR Exon 20 Insertion Mutation with Response to Poziotinib.
Yang J; Yang J; Ban S; Li X; Chen X; Yang J; Qian J
J Thorac Oncol; 2019 Sep; 14(9):e198-e200. PubMed ID: 31445735
[No Abstract] [Full Text] [Related]
16. Isolation of the gene for the B12-dependent ribonucleotide reductase from Anabaena sp. strain PCC 7120 and expression in Escherichia coli.
Gleason FK; Olszewski NE
J Bacteriol; 2002 Dec; 184(23):6544-50. PubMed ID: 12426342
[TBL] [Abstract][Full Text] [Related]
17. The Next Wave of EGFR Tyrosine Kinase Inhibitors Enter the Clinic.
Politi K; Ayeni D; Lynch T
Cancer Cell; 2015 Jun; 27(6):751-3. PubMed ID: 26058074
[TBL] [Abstract][Full Text] [Related]
18. [Treatment challenges in patients with ALK-positive non-small cell lung cancer and brain metatases].
Zhou JY; Chen Q; Zhou JY
Zhonghua Jie He He Hu Xi Za Zhi; 2018 Oct; 41(10):755-759. PubMed ID: 30347546
[No Abstract] [Full Text] [Related]
19. Multiple Acquired Resistance Mutations of the ALK Tyrosine Kinase Domain after Sequential Use of ALK Inhibitors.
Wang HY; Ho CC; Shih JY
J Thorac Oncol; 2017 May; 12(5):e49-e51. PubMed ID: 28434515
[No Abstract] [Full Text] [Related]
20. The first holocomplex structure of ribonucleotide reductase gives new insight into its mechanism of action.
Uppsten M; Färnegårdh M; Domkin V; Uhlin U
J Mol Biol; 2006 Jun; 359(2):365-77. PubMed ID: 16631785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
